Results out today confirm that the drug donanemab, hailed as a turning point in the fight against Alzheimer’s, slows cognitive decline by about a third.
The antibody treatment helps in the early stages of the disease.
It works in Alzheimer’s disease, not in other types of dementia, such as vascular dementia.
That is because it is designed to clear away one of the key features of Alzheimer’s disease – a substance called amyloid that builds up in the spaces between brain cells.
Please subscribe here: http://bit.ly/1rbfUog
#Dementia #Alzheimers #BBCNews
An Israeli air strike on a town in southern Lebanon has killed six people, including three paramedics, according to Lebanon's…
NAPOLI (ITALPRESS) – Intervenendo a Sorrento al forum Verso Sud di Teha Group (The European House – Ambrosetti), il vicepresidente…
NAPOLI (ITALPRESS) – Intervenendo a Sorrento al forum Verso Sud di Teha Group (The European House – Ambrosetti), il vicepresidente…
ROMA (ITALPRESS) – L’Iran farebbe meglio a trovare un accordo, altrimenti passerà momenti molto brutti”. Lo ha detto il presidente…
ROMA (ITALPRESS) – L’Iran farebbe meglio a trovare un accordo, altrimenti passerà momenti molto brutti”. Lo ha detto il presidente…
ROMA (ITALPRESS) – “Quanto accaduto oggi a Modena, dove un uomo ha investito diversi pedoni e poi avrebbe accoltellato un…